Related Experiment Video
Updated: Jun 13, 2026
08:47
Spectral Confocal Imaging of Fluorescently tagged Nicotinic Receptors in Knock-in Mice with Chronic Nicotine Administration
Published on: February 10, 2012
Cognitive effects of nicotine: genetic moderators
Aryeh I Herman1, Mehmet Sofuoglu
1Department of Psychiatry and VA Connecticut Healthcare System, School of Medicine, Yale University, West Haven, CT 06516, USA.
Addiction Biology
|May 12, 2010
Summary
Nicotine enhances cognitive function, with specific genes like beta2 nicotinic acetylcholine receptors (nAChRs) playing a key role. Understanding these genetic links is crucial for developing better smoking cessation treatments.
Area of Science:
- Neuroscience
- Pharmacology
- Genetics
Background:
- Cigarette smoking is a leading preventable cause of death.
- Nicotine's cognitive-enhancing effects are increasingly recognized.
- Effective smoking cessation treatments are needed.
Purpose of the Study:
- To explore the genetic underpinnings of nicotine-induced cognitive enhancement.
- To identify specific genes and receptors involved in nicotine's effects on cognition.
- To understand how genetic variations influence cognitive responses to nicotine.
Main Methods:
- Review of existing genetic studies on nicotine and cognition.
- Analysis of knockout mice studies.
- Examination of genetic variations in dopamine (DA) and serotonin pathways.
Main Results:
- Beta2 nicotinic acetylcholine receptors (nAChRs) are crucial for nicotine's cognitive effects.
- Alpha7 nAChRs are linked to attention and sensory filtering, particularly in schizophrenia.
- Genetic variations in D2 DA receptors, COMT, and 5-HTT moderate nicotine's cognitive impact.
Conclusions:
- Specific genetic factors, including nAChRs and DA-related genes, mediate nicotine's cognitive-enhancing properties.
- Further research is needed to fully elucidate the mechanisms of nicotine's cognitive effects.
- Understanding these genetic mechanisms may lead to improved smoking cessation strategies.
Related Concept Videos
01:23Drugs Acting on Autonomic Ganglia: Stimulants
Ganglionic stimulants activate NM nicotinic receptors in autonomic ganglia, falling into two categories: nicotine mimetics [e.g., lobeline, dimethylpiperazine, tetramethylammonium] and muscarinic receptor agonists [e.g., muscarine, methacholine]. The first category's action is rapid and blocked by nicotinic receptor antagonists, while the second category's action is delayed and blocked by atropine-like agents. Nicotine, an alkaloid, affects the heart rate by stimulating sympathetic or...
01:28Human Genetics
Human genetics provides a profound framework for understanding the interplay between genetic predispositions and human psychology. At the heart of this discipline lies the study of how genes influence physical traits, behaviors, and susceptibility to diseases. Each person carries a unique genetic code that subtly or significantly shapes their psychological and behavioral landscape.
The complex relationship between genetics and psychology is observable through common biological components such...
The complex relationship between genetics and psychology is observable through common biological components such...
01:27CNS Depressants: Alcohol and Nicotine
Ethanol, a clear colorless alcohol, has been consumed by humans for millennia, but its effects on the body are far from benign. At lower doses, it induces decreased inhibitions and loquaciousness, leading to its social appeal. However, it can cause severe consequences at higher doses, such as coma and respiratory depression, due to its zero-order elimination kinetics. Chronic ethanol abuse wreaks havoc on multiple organ systems, particularly the CNS and the liver. Abrupt cessation of ethanol...
01:29Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu
Genetic variations significantly influence drug response through pharmacokinetics, receptor interactions, and biologic milieu modifications. Pharmacokinetic alterations impact drug metabolism and clearance, affecting efficacy and toxicity. Variants in drug-metabolizing enzymes, such as CYP2C9 and CYP2C19, alter drug activation and elimination. For example, CYP2C9 loss-of-function variants require lower warfarin doses to prevent excessive bleeding, while CYP2C19 variants reduce clopidogrel...
01:29Stimulants
Stimulants are substances that enhance neural activity and elevate dopamine levels in the brain, leading to their highly addictive nature. These drugs include cocaine, amphetamines, MDMA, caffeine, and nicotine, each with distinct mechanisms of action and varied health implications.
Cocaine can be administered via snorting, injection, or smoking. It primarily functions by blocking the reuptake of dopamine, resulting in a euphoric high characterized by an intense sensation of happiness and...
Cocaine can be administered via snorting, injection, or smoking. It primarily functions by blocking the reuptake of dopamine, resulting in a euphoric high characterized by an intense sensation of happiness and...
01:27Principles of Pharmacogenetics: Types of Genetic Variants
The human genome is over 99.9% identical between individuals, yet genetic differences exist at millions of bases. The human genome contains approximately 3 million variant positions per individual, many of which are heterozygous, contributing to genetic diversity and individual traits. Genetic variations include single-nucleotide polymorphisms (SNPs), insertions, deletions, and copy number variations (CNVs).SNPs, the most common variation, involve single-base changes in DNA. These can be...